Subtype-specific micro-RNA expression signatures in breast cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Breast cancer heterogeneity necessitates subtype-specific analysis for identifying invasive disease markers.
• MicroRNA (miRNA) alterations are implicated in breast cancer progression.
• Distinguishing ductal carcinoma in situ (DCIS) from invasive carcinoma is crucial for treatment decisions.

Purpose of the Study:

• To identify robust, subtype-specific microRNA (miRNA) signatures associated with invasive breast cancer.
• To validate a microRNA signature for ductal carcinoma in situ (DCIS) with potential for invasiveness.
• To investigate miRNA expression changes during breast cancer progression across different molecular subtypes.

Main Methods:

• Analysis of two independent breast cancer datasets (METABRIC and AHUS) comprising normal tissue, DCIS, and invasive carcinoma samples.
• Stratification of samples by molecular subtypes using immunohistochemistry, PAM50, and integrated cluster classifications.
• External validation of identified miRNA signatures.

Main Results:

• Subtype-specific miRNA signatures for invasive breast cancer were identified, including downregulation of miR-139-5p in aggressive subtypes and upregulation of miR-29c-5p in luminal subtypes.
• A validated miRNA signature for DCIS was proposed, featuring upregulation of miR-21-5p and the miR-200 family, and downregulation of let-7 family members.
• No universal miRNA changes were observed during the DCIS to invasive carcinoma transition, highlighting the importance of subtype stratification.

Conclusions:

• Proposed miRNA signatures can aid in identifying DCIS with higher invasive potential.
• These signatures may serve as a basis for developing serum biomarkers for both in situ and invasive breast cancer.
• Subtype-specific miRNA analysis is essential for understanding breast cancer progression and identifying robust biomarkers.